Keywords
Cohn’s disease
Ulcerative Colitis
Diagnosis
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To evaluate the time to diagnosis of Inflammatory Bowel Diseases (IBD) in a center in northeastern Brazil. Methods: Observational, retrospective and cross-sectional study. Data were collected from the hospital’s electronics medical records, including patients over 18 years old who were treated from 2013 to 2021 and who had a confirmed diagnosis of Crohn’s disease (CD) or ulcerative colitis (UC). Results: 678 patients were included, of which 346 had UC and 332 had CD. The time to diagnosis of IBD had an average of 24,8 months and a median of 9,0 months (range from 1 month to 432 months). The median CD diagnostic delay was greater for behaviors B2 (stenosing) with 12 months and B3 (penetrating) with 20 months. The median delay in diagnosis of UC had statistically significant results (P<0,05) for the extent of the disease, with E3 (pancolitis: 8,0 months) < E2 (left colitis: 9,0 months) < E1 (proctitis: 9,5 months). Conclusion: The results of this study indicated that the time to diagnosis of IBD had a large temporal variation and these results were influenced by the extent of UC and the behavior of CD. This diagnostic delay can negatively impact the prognosis of IBD.
References
ALATAB S, et al. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet Gastroenterology & Hepatology, 2020; 5(1): 17–30.
ARIEIRA C et al. Clinical course in Crohn’s disease: factors associated with behaviour change and surgery. Scandinavian Journal of Gastroenterology, 2018; 53: 1222–1227.
BANERJEE R, et al. Emerging inflammatory bowel disease demographics, phenotype, and treatment in South Asia, South-East Asia, and Middle East: Preliminary findings from the Inflammatory Bowel Disease-Emerging Nations’ Consortium. Journal of Gastroenterology and Hepatology, 2022; 37(6): 1004-1015.
BARROS KSC, et al. Evolution of Clinical Behavior in Crohn’s Disease: Factors Associated with Complicated Disease and Surgery. Digestive Diseases and Sciences, 2017; 6(9): 2481–2488.
CANTORO L, et al. The Time Course of Diagnostic Delay in Inflammatory Bowel Disease Over the Last Sixty Years: An Italian Multicentre Study. Journal of Crohn’s & Colitis, 2017; 11 (8): 975–980.
DESAI D. Disease Behaviour in Patients with Crohn’s Disease: A Review. Gastroenterology & Hepatology: Open Access, 2015; 3 (2).
FEUERSTEIN JD e CHEIFETZ AS. Crohn Disease: Epidemiology, Diagnosis, and Management. Mayo Clinic Proceedings, 2017; 92 (7): 1088–1103.
GASPARINI RG, et al. Inflammatory bowel disease epidemiology in São Paulo State, Brazil. Clinical and Experimental Gastroenterology, 2018; 11: 423–429.
HERESBACH D, et al. Crohn’s disease in the over-60 age group: a population based study. European Journal of Gastroenterology & Hepatology, 2004;16(7): 657–664.
LAKATOS PL, et al. IBD in the elderly population: Results from a population-based study in Western Hungary, 1977–2008. Journal of Crohn’s and Colitis, 2011; 5(1): 5–13.
LIMA MARTINS A, et al. The prevalence and phenotype in Brazilian patients with inflammatory bowel disease. BMC Gastroenterology, 2018; 18 (1).
MAK WY, et al. The epidemiology of inflammatory bowel disease: East meets west. Journal of Gastroenterology and Hepatology, 2020; 35 (3): 380–389.
MOLANDER P e YLÄNNE K. Impact of ulcerative colitis on patients’ lives: results of the Finnish extension of a global ulcerative colitis narrative survey. Scandinavian Journal of Gastroenterology, 2019; 54 (7): 869–875.
MOREIRA AL, et al. IBD Epidemiology: What is Going on in the Developing World? Results from 163,000 Patients. Gastroenterology, 2019; 362(73).
NAHON P, et al. Incidence of Hepatocellular Carcinoma After Direct Antiviral Therapy for HCV in Patients With Cirrhosis Included in Surveillance Programs. Gastroenterology, 2018; 155(5): 1436- 1450.
OUAZ A, et al. Changes of Crohn’s disease phenotype over time. La Tunisie Medicale, 2016; 94(6): 167–170.
PARENTE JML, et al. Inflammatory bowel disease in an underdeveloped region of Northeastern Brazil. World Journal of Gastroenterology, 2015; 21(4): 1197–1206.
SAIRENJI T, et al. An Update on Inflammatory Bowel Disease. Primary Care, 2017; 44 (4): 673–692.
SIMIAN D, et al. Inflammatory bowel disease: A descriptive study of 716 local Chilean patients. World Journal of Gastroenterology, 2016; 22: 5267–5275.
KAPLAN GG e WINDSOR JW. Thefour epidemiological stages in the global evolution of inflammatory bowel disease. Nature Reviews, 2021; 18.
TORRES, U. DOS S. et al. The Montreal classification for Crohn’s disease: clinical application to a Brazilian single-center cohort of 90 consecutive patients. Arquivos De Gastroenterologia, 2010; 47(3): 279–284.
VICTORIA, C. R et al. Incidence and prevalence rates of inflammatory bowel diseases, in midwestern of São Paulo State, Brazil. Arquivos de Gastroenterologia, 2009; 46: 20–25.
VUCELIC, B. Inflammatory bowel diseases: controversies in the use of diagnostic procedures. Digestive Diseases (Basel, Switzerland), 2009; 27(3): 269–277.
WALKER GJ, et al. Quality improvement project identifies factors associated with delay in IBD diagnosis. Alimentary Pharmacology & Therapeutics, 2020; 52(3): 471–480.
YU YR e RODRIGUEZ JR. Clinical presentation of Crohn’s, ulcerative colitis, and indeterminate colitis: Symptoms, extraintestinal manifestations, and disease phenotypes. Seminars in Pediatric Surgery, 2017; 26(6): 349–355.